PSIL

AdvisorShares Psychedelics ETF

• Benzinga·4d ago

  COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy

• Seeking Alpha·01/22 12:15

  2025 ETF Wrap-Up And What To Expect In 2026

• NASDAQ·12/31/2025 16:00

  Best-Performing Active ETFs of 2025

• Seeking Alpha·09/22/2025 10:13

  AdvisorShares Psychedelics ETF declares quarterly distribution of $0.0200

• Benzinga·08/05/2025 18:25

  Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug

• NASDAQ·06/20/2025 14:00

  5 ETFs That Beat the Market in the First Half of 2025

• Benzinga·06/11/2025 19:39

  'Texas Governor Signs Bill To Create Ibogaine Research Consortium, Aiming To Develop FDA-Approved Psychedelic Drug' - Marijuana Moment

• Benzinga·06/10/2025 16:57

  "Colorado Governor Says Bill He Signed Allowing Psychedelic Convictions To Be Pardoned Marks A Step 'Towards A Fairer Future'" - Marijuana Moment

• Benzinga·06/06/2025 14:50

  'Doctor Seeking To Reschedule Psilocybin To Treat Dying Patients Demands DEA Update After Agency Agreed To Initiate Federal Review' - Marijuana Moment

• Benzinga·05/24/2025 20:11

  Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors

• NASDAQ·03/28/2025 14:20

  The Zacks Analyst Blog Highlights SGDM, SLVP, SHLD, COPJ and PSIL

• NASDAQ·03/27/2025 14:00

  5 Sector ETFs That Have Outperformed the S&P 500 in Q1